Aspirin 300mg gastro-resistant tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Aspirin

Available from:

The Boots Company Plc

ATC code:

N02BA01

INN (International Name):

Aspirin

Dosage:

300mg

Pharmaceutical form:

Gastro-resistant tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 04070100

Patient Information leaflet

ASPIRIN 300MG GASTRO-RESISTANT TABLETS
(acetylsalicylic acid)
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor or pharmacist.
*
This medicine has been prescribed for you. Do not pass it on to
others. It
may harm them, even if their symptoms are the same as yours.
*
If any of the side effects gets serious, or if you notice any side
effects not
listed in this leaflet please tell your doctor or pharmacist.
Your medicine is called Aspirin 300mg Gastro-resistant Tablets but
will be
referred to as Aspirin 300mg throughout the rest of this leaflet.
IN THIS LEAFLET:
What Aspirin 300mg is and what it is taken for
Check before you take Aspirin 300mg
How to take Aspirin 300mg
Possible side effects
How to store Aspirin 300mg
Further information
WHAT ASPIRIN 300MG IS AND WHAT IT IS TAKEN FOR
Aspirin 300mg is used:
*
as an anti-inflammatory analgesic which can relieve pain and swelling
*
to bring down high body temperatures
*
to prevent recurrence of heart attacks or strokes by thinning the
blood.
If someone who has previously had a heart attack or stroke takes
Aspirin
300mg regularly, it reduces the risk of a blood clot occurring in the
heart
or brain. This can prevent further heart attacks or strokes.
IF YOU TAKE ASPIRIN IN HIGH DOSES OR OVER A LONG PERIOD OF TIME, IT
CAN
IRRITATE YOUR STOMACH LINING. TO PREVENT STOMACH IRRITATION, THESE
TABLETS
HAVE A SPECIAL COATING (CALLED ENTERIC) SO THAT THE ASPIRIN IS NOT
RELEASED UNTIL IT HAS PASSED THROUGH THE STOMACH.
Aspirin is released slowly from these tablets, so Aspirin 300mg is not
suitable for the short-term relief of pain, such as headaches or
toothache.
CHECK BEFORE YOU TAKE ASPIRIN 300MG
DO NOT TAKE ASPIRIN 300MG:
*
if you are allergic to aspirin or if you are allergic to any of the
ingredients in
Aspirin 300mg (see Section 6 Further information)
*
if you have ever had the problem of your blood not clotting properly
*

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Aspirin 300mg Gastro-resistant Tablets
Postmi 300mg Gastro-resistant Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 300mg Aspirin
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Gastro-resistant tablet
Round,
cylindrical
biconvex
tablets
with
a
glossy
pink
coating,
printed
POSTMI 300EC or Aspirin 300EC in black on one side.
4.1
THERAPEUTIC INDICATIONS
Aspirin 300mg Tablets contain an anti-pyretic, anti inflammatory and
analgesic, and
are gastro-resistant to reduce the gastric side-effects of aspirin in
rheumatoid arthritis
and in conditions requiring continued management with aspirin.
Aspirin may be used to reduce the risk of myocardial infarction in
patients with
unstable angina or in patients with a previous history of myocardial
infarction.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Analgesic, anti-inflammatory, anti-pyretic;
Adults (including the elderly) and children over 16 years:
3 tablets (900mg) 3-4 times daily as required, at least 4 hours apart.
Anti-thrombotic effect – to reduce the risk of myocardial
infarction:
One tablet daily
Paediatric population
Do not give to children under 16 years, unless specifically indicated
(e.g. for
Kawasaki’s disease).
Method of administration
For oral administration.
Aspirin must not be chewed or crushed. The tablets are best taken
before
meals.
4.3
CONTRAINDICATIONS
Aspirin should not be administered to patients:
•
with
hypersensitivity
to the
active
substance, other
NSAIDs,
or
to any
of
the
excipients listed in section 6.1;
•
with active peptic ulceration or a history of peptic ulceration and/or
gastric/intestinal
haemorrhage, or other kinds of bleeding such as cerebrovascular
haemorrhages;
•
with haemophilia and other bleeding disorders;
•
for the treatment of gout;
•
who are breastfeeding (see section 4.6).
•
with severe hepatic impairment;
•
with severe renal impairment;
•
taking Methotrexate used at doses >15mg/week (see